---
title: "ASCO guideline-of-breast cancer"
slug: "asco-guideline-of-breast-cancer"
date: "2023-10-09"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[breast cancer]]

# ASCO guideline-of-breast cancer

- [[Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer]]
- [[Endocrine Treatment and Targeted Therapy for HR-Positive, HER2-Negative Metastatic Breast Cancer]]
- [[Biomarkers for Systemic Therapy in Metastatic Breast Cancer]] Guideline and Rapid Update
- [[Chemo- and Targeted Therapy for Patients With HER2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative]]
- [[Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer]]
- [[Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases]]
- [[Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer]]
- [[Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer]] âš¡
- [[Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer]]
- [[Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer]]
- [[Early-Stage Triple-Negative Breast Cancer Journey Beginning, End, and Everything in Between]]
